Recent Press Releases

Cummings Issues Statement on Martin Shkreli's Subpoena to Appear Before Oversight Committee

Cummings Issues Statement on Martin Shkreli's Subpoena to Appear Before Oversight Committee Washington, DC (Jan. 21, 2016)—This morning, Democratic and Republican staff on the House...

Global pharmaceutical industry calls on governments to work with them to beat the rising threat of drug resistance

21 January 2016 Issued: London More than 80 leading international pharmaceutical, generics, diagnostics and biotechnology companies, as well as key industry bodies, have come together to call on...

Novartis receives two new FDA approvals for Cosentyx® (secukinumab) to treat patients with ankylosing spondylitis and psoriatic arthritis

EAST HANOVER, N.J., Jan. 15, 2016 /PRNewswire/ -- Novartis announced today that the US Food and Drug Administration (FDA) has approved Cosentyx® (secukinumab) for two new indications - the...

Eisai's Lenvatinib Receives FDA Priority Review for the Potential Treatment of Advanced Renal Cell Carcinoma in Combination with Everolimus

WOODCLIFF LAKE, N.J., Jan. 17, 2016 /PRNewswire/ -- Eisai Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental New Drug Application...

Merck Appoints New Executive Board Members

Udit Batra and Walter Galinat promoted to the Executive Board Bernd Reckmann to retire Darmstadt, Germany, January 19, 2016 – The Board of Partners of E. Merck KG has appointed two new members...

Eisai's Lenvatinib Receives FDA Priority Review for the Potential Treatment of Advanced Renal Cell Carcinoma in Combination with Everolimus

Supplemental application based on progression-free survival data from Study 205, a three-arm Phase 2 study comparing lenvatinib in combination with everolimus, everolimus alone and lenvatinib alone...

Johnson & Johnson Announces Actions To Strengthen Medical Devices Leadership Position In Evolving Healthcare Marketplace

Restructuring Designed to Accelerate Pace of Innovation, Address Unmet Patient Needs and Drive Growth Identifies Projected, Annualized Pre-Tax Cost Savings of $800 Million to $1.0 Billion, with...

Merck Sues Merck KGaA, Darmstadt, Germany for Improper Use of "Merck"

Friday, January 15, 2016 6:22 am EST PDFPrint KENILWORTH, N.J. – Merck (NYSE: MRK), known as MSD outside the United States and Canada, has been operating in the United States under the name...

Merck KGaA, Darmstadt, Germany Announces Favorable UK Court Ruling on Name Use

• Court says MSD breached an agreement with Merck KGaA, Darmstadt, Germany in the UK by using "Merck" alone either as a trade mark or a name Darmstadt, Germany, January 15, 2016...

Merck Resolves Previously Disclosed Securities Class Action Lawsuit Related to Vioxx

Friday, January 15, 2016 7:00 am EST PDFPrint KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that it has reached an agreement...

Akorn Provides Material Updates

- BDO USA, LLP Engaged as Independent Registered Public Accounting Firm - - Nasdaq Listing Extension Granted Through May 9, 2016 - - Conference Call Scheduled for 8:00 am ET on January 15, 2016 -...

Pfizer Acquires Treerly and Its Family of Products from Sirio Pharma

SHANGHAI--(BUSINESS WIRE)-- Pfizer Inc. (PFE) announced today that it has acquired Sirio Pharma Co. Ltd.'s wholly-owned subsidiary, Treerly Health Co., Ltd., and its family of Treerly products....

Prescription Drug Prices Climbed 10.43 Percent in 2015, Further Squeezing Consumer Wallets as Lawmakers Step up Scrutiny

NEW YORK--(BUSINESS WIRE)--Amidst increasing consumer concerns and mounting scrutiny from lawmakers, a new report indicates prescription drug prices rose 10.43 percent in 2015 – continuing to...

Organizational Changes Strengthen Leadership Team and Position Celgene for Long-Term Growth

- Bob Hugin to continue to lead strategic direction of Company in the role of Executive Chairman - Mark Alles to be promoted to Chief Executive Officer - Jacqualyn Fouse, PhD, to be promoted to...

Over 50 Members of Congress to Obama Administration: Help End Drug Price Gouging Now

FOR IMMEDIATE RELEASE January 11, 2016 Contact: Leslie Tisdale, (202) 225-4865 Over 50 Members of Congress to Obama Administration: Help End Drug Price Gouging Now Washington—Today, over 50...

Vertex Outlines 2016 Business Priorities to Support the Discovery and Development of New Transformative Medicines for the Treatment of Cystic Fibrosis and Other Serious Diseases

-Approximately 25,000 people with cystic fibrosis worldwide currently eligible for treatment with ORKAMBI® (lumacaftor/ivacaftor) or KALYDECO® (ivacaftor); Vertex advancing the development of...

Aegerion Pharmaceuticals Appoints Mary Szela as Chief Executive Officer

Sandford D. Smith Appointed as Chairman of Aegerion's Board of Directors CAMBRIDGE, Mass., Jan. 07, 2016 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), a biopharmaceutical...

FDA Grants Priority Review to AbbVie for Supplemental New Drug Application for Viekira Pak (Ombitasvir, Paritaprevir, Ritonavir Tablets; Dasabuvir Tablets) Without Ribavirin in Genotype 1b Chronic Hepatitis C Virus Patients With Compensated Cirrhosis

FDA GRANTS PRIORITY REVIEW TO ABBVIE FOR SUPPLEMENTAL NEW DRUG APPLICATION FOR VIEKIRA PAK (OMBITASVIR, PARITAPREVIR, RITONAVIR TABLETS; DASABUVIR TABLETS) WITHOUT RIBAVIRIN IN GENOTYPE 1B CHRONIC...